Large-scale computational drug repositioning to find treatments for rare diseases

Rare, or orphan, diseases are conditions afflicting a small subset of people in a population. Although these disorders collectively pose significant health care problems, drug companies require government incentives to develop drugs for rare diseases due to extremely limited individual markets. Comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Govindaraj, Rajiv Gandhi, Naderi, Misagh, Singha, Manali, Lemoine, Jeffrey, Brylinski, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Technology Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847522/
https://www.ncbi.nlm.nih.gov/pubmed/29560273
http://dx.doi.org/10.1038/s41540-018-0050-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847522/
https://www.ncbi.nlm.nih.gov/pubmed/29560273
http://dx.doi.org/10.1038/s41540-018-0050-7

Ejemplares similares